Caption Management’s Immunogen Inc IMGN Stock Holding History

Caption Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-360,400	Closed	-$10.7M	–	1782
2023 Q4	$10.7M	Buy	360,400 +335,400	+1,342%	+$6.68M	0.14%	174
2023 Q3	$397K	Sell	25,000 -85,000	-77%	-$1.41M	0.01%	985
2023 Q2	$2.08M	Buy	+110,000	New	+$1.3M	0.04%	485
2022 Q1	–	Sell	-200,000	Closed	-$1.48M	–	2078
2021 Q4	$1.48M	Hold	200,000	–	–	0.02%	899
2021 Q3	$1.13M	Sell	200,000 -97,500	-33%	-$563K	0.01%	982
2021 Q2	$1.96M	Buy	+297,500	New	+$2.08M	0.03%	680
2019 Q3	–	Sell	-90,000	Closed	-$195K	–	937
2019 Q2	$195K	Sell	90,000 -135,000	-60%	-$319K	0.01%	571
2019 Q1	$610K	Buy	+225,000	New	+$975K	0.03%	427

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's IMGN Position: Q4 2023 in Review

Caption Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 40,600 shares — an estimated $808K sold.

Caption Management first reported a position in IMGN in Q3 2018 and held it in 10 quarters. The position peaked at $819K in Q4 2018. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

Caption Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
Caption Management sold 40,600 Immunogen Inc shares in Q4 2023, an estimated $808K.
Caption Management first reported a position in Immunogen Inc in Q3 2018 and held it in 10 quarters.
Caption Management's Immunogen Inc position peaked at $819K in Q4 2018.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.